


Ixekizumab May Improve Pain & Sexual Health in Patients with Genital Psoriasis

FDA Update: New Drug Approvals, New & Expanded Indications, & More

Phase 3 Results for Ixekizumab Promising in Patients with Non-Radiographic Axial Spondyloarthritis

FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis

Ixekizumab vs. Adalimumab for PsA: How Do They Compare?

A New Treatment for Axial Spondyloarthritis?

Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus

Rheumatology Drugs at a Glance, Part 2: Psoriasis
